Lazard Asset Management’s Radius Health, Inc. RDUS Stock Holding History

Lazard Asset Management’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,231	Closed	-$74K	–	2628
2022 Q2	$74K	Buy	7,231 +6,040	+507%	+$44.9K	﹤0.01%	1636
2022 Q1	$10K	Buy	+1,191	New	+$9.03K	﹤0.01%	2141
2021 Q1	–	Sell	-4,834	Closed	-$86K	–	2092
2020 Q4	$86K	Sell	4,834 -2,025	-30%	-$30.4K	﹤0.01%	1221
2020 Q3	$77K	Sell	6,859 -51,344	-88%	-$635K	﹤0.01%	1068
2020 Q2	$793K	Buy	58,203 +53,606	+1,166%	+$738K	﹤0.01%	783
2020 Q1	$59K	Buy	4,597 +3,526	+329%	+$62.9K	﹤0.01%	1124
2019 Q4	$21K	Buy	1,071 +372	+53%	+$9.03K	﹤0.01%	1225
2019 Q3	$17K	Buy	+699	New	+$17.1K	﹤0.01%	1123

Other funds holding RDUS

RCG

Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Lazard Asset Management's RDUS Position: Q3 2022 in Review

Lazard Asset Management sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 7,231 shares — an estimated $74K sold.

Lazard Asset Management first reported a position in RDUS in Q3 2019 and held it in 8 quarters. The position peaked at $793K in Q2 2020. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

Lazard Asset Management reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
Lazard Asset Management sold 7,231 Radius Health, Inc. shares in Q3 2022, an estimated $74K.
Lazard Asset Management first reported a position in Radius Health, Inc. in Q3 2019 and held it in 8 quarters.
Lazard Asset Management's Radius Health, Inc. position peaked at $793K in Q2 2020.
1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.